Featured GeneDx blog posts

Prenatal Exome-to-Genome Reflex gives providers a flexible way to begin with exome sequencing while preserving a seamless path to genome analysis when additional answers are needed—all from one order and one sample.

New research presented at the Medicaid Health Plans of America Annual Conference found that, among children with developmental delay, intellectual disability, and epilepsy who underwent stepwise genetic testing, prior testing added an average of 19 months and $2,039 in genetic testing costs before exome or genome sequencing (ES/GS).

‍

In a budget impact analysis of 5,821 children covered by Medicaid, a first-tier ES/GS approach was associated with an estimated $294 in savings per patient per year over five years. Some Medicaid plans have already updated their coverage policies in response to evidence and professional society guidance. These findings support continued modernization among the remaining plans that still require prior testing, with the potential to reduce unnecessary testing, shorten time to diagnosis, and improve long-term budget performance.